BackAllogene Therapeutics Overview
Allogene Therapeutics Inc

Allogene Therapeutics Target Price

Analysts' 12-month price predictions for ALLO.

Get informed when a big investor buys or sells

+ Follow

Share Price

$2.07

Average Target Price

$6.42210.4% upside

2 analysts in the last 4 months

High: $9 | Low: $3.85

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-04-14Bernstein$3.8586% upsideOpen
2026-04-14Robert W. Baird$9334.8% upsideOpen
2024-05-16H.C. WainwrightDebjit Chattopadhyay$9334.8% upsideOpen
2024-05-14B.Riley FinancialKalpit Patel$7238.2% upsideOpen
2022-06-13Robert W. BairdJack Allen$11431.4% upsideOpen
2022-01-03GuggenheimMichael Schmidt$351590.8% upsideOpen
2021-12-03Canaccord GenuityJohn Newman$552557% upsideOpen
2021-10-08Roth CapitalAnthony Butler$351590.8% upsideOpen
2021-10-08Bank of America SecuritiesJason Gerberry$321445.9% upsideOpen
2021-10-08OppenheimerMark Breidenbach$401832.4% upsideOpen
2021-10-08JefferiesBiren Amin$301349.3% upsideOpen
2021-09-23Raymond JamesDane Leone$361639.1% upsideOpen